Corporate News

• 
  Beilu Pharma's Iohexol Injection Won the Bid in the Fifth round of National Centralized Drug Procurement

  2021/06/24

  Beilu Pharma participated in the fifth round of national centralized drug procurement organized by the National Organization for Centralized Drug Procurement and Use of the Joint Procurement Office.

  VIEW_MORE
• 
  Congratulations: Beilu Pharma's Iodixanol Injection Passed the Consistency Evaluation for Generic Drugs

  2021/05/18

  Beijing Beilu Pharmaceutical Co., Ltd received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (NMPA) on Iodixanol Injection.

  VIEW_MORE
• 
  Congratulations: Beilu Pharma's Iohexol Injection Passed the Consistency Evaluation for Generic Drugs

  2021/04/21

  Recently, Beijing Beilu Pharmaceutical Co., Ltd received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration (NMPA).

  VIEW_MORE
• 
  Good News: Beilu Pharmaceutical won the 2020 National Adverse Drug Reactions Monitoring and Evaluation Excellent Unit

  2021/04/12

  On March 11th, the National Medical Products Administration (NMPA) issued the “Notice Recognizing Excellent Units in the National Adverse Drug Reactions Monitoring and Evaluation 2020”.

  VIEW_MORE
• 
  Big News! Beilu Pharmaceutical Acquired Hichi Pharmaceutical to Strengthen the Layout of Contrast Agent APIs

  2021/03/01

  Beilu Pharmaceutical Co., Ltd. (www.beilupharma.com) issued the Outbound Investment Announcement: Shareholders of Beilu Pharmaceuticals and Zhejiang Hichi Pharmaceutical Co., Ltd.

  VIEW_MORE